| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PetVivo Holdings, Inc. | Director | Common Stock | 67.4K | $149K | $2.21 | Apr 24, 2021 | Direct |
| Cocrystal Pharma, Inc. | Co-CEO and CFO | Stock Options (Right to Buy) | 30K | Jul 18, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| COCP | Cocrystal Pharma, Inc. | Jul 18, 2023 | 1 | $0 | 4 | Jul 20, 2023 | Co-CEO and CFO |
| COCP | Cocrystal Pharma, Inc. | Jul 25, 2022 | 1 | $0 | 4 | Aug 3, 2022 | Co- Interim CEO and CFO |
| COCP | Cocrystal Pharma, Inc. | Jul 16, 2021 | 1 | $0 | 4 | Jul 20, 2021 | Chief Financial Officer |
| PETV | PetVivo Holdings, Inc. | May 24, 2021 | 1 | $21K | 4 | May 26, 2021 | Director |